NEW YORK, January 24, 2023 /PRNewswire/ — The GERD Market by Route of Administration, Type and Geography – Forecast and Analysis 2023-2027 the report was published by Technavio. The market size is expected to grow by 908.49 million US dollars between 2022 and 2027 on a CAGR of 3.4%. The report provides a comprehensive analysis of regional growth opportunities, new product launches, latest trends, and post-pandemic global market recovery. Download a PDF sample report
Regional analysis
By region, the global GERD market is segmented into North America, Europe, Asiaand the rest of the world (ROW). North America will report 38% market growth during the forecast period. Factors such as increasing preference for over-the-counter drugs and self-medication practice among the population are driving the growth of the GERD market in North America. Buy the report
Company profiles
The GERD market report includes information on the key products and recent developments of leading vendors, including:
-
Bayer AG – The company offers GERD drugs such as abbott pantoprazole.
-
Alkem Laboratoris EOOD – The company offers drugs for GERD such as esokem and omee.
-
Apotex Inc. – The company offers GERD drugs such as famotidine.
-
AstraZeneca Plc – The company offers GERD drugs such as nexium 20 mg.
Market dynamics
The market is driven by factors such as the growing geriatric population, poor lifestyles, and excessive use of drugs and nutritional supplements. However, the growing preference for CAM of complementary and alternative medicine is hindering the growth of the market.
Competitive analysis
The competitive scenario categorizes companies based on various performance metrics. Some of the factors considered include companies’ financial performance over the past few years, growth strategies, product innovation, new product launches, investments and market share growth, among others. Request a sample
Market segmentation
-
By administration, the market is segmented into oral and parenteral. The oral segment accounts for the largest share of the market in 2022.
-
By geography, the market is segmented into North America, Europe, Asiaand the rest of the world (ROW). North America hold the largest share of the market in 2022.
Related reports:
-
The human combination vaccine market is expected to grow at a CAGR of 8.13% between 2022 and 2027. The market size is expected to increase by 6,046.98 million US dollars. The rise in the incidence of infectious diseases is significantly driving the market growth, although factors such as incompatibility of vaccine components may hinder the market growth.
-
The food market is expected to grow at a CAGR of 4.48% between 2022 and 2027. The market size is expected to increase by $34.79 billion. The growing geriatric population in particular is driving the growth of the market, although factors such as product recalls may hinder the growth of the market.
Technavio’s library includes over 17,000+ reports covering more than 2,000 emerging
technologies. Subscribe to our “Basic Plan” on samo 5000 USD and get lifetime access to
Technavio Insights
What are the key data included in this GERD market report?
-
Market CAGR during the forecast period.
-
Detailed information on factors that will drive market growth between 2023 and 2027
-
An accurate estimate of the GERD market size and its contribution to the parent market.
-
Accurate predictions of upcoming trends and changes in consumer behavior.
-
Market growth North America, Europe, Asiaand the rest of the world (ROW).
-
In-depth analysis of the competitive landscape of the market and detailed information on suppliers.
-
A comprehensive analysis of the factors that will drive the growth of vendors in the GERD market.
Market scope of GERB |
|
Report coverage |
Details |
Page number |
166 |
Base year |
2022 |
Historical period |
2017-2021 |
Estimated period |
2023-2027 |
Growth momentum and CAGR |
Accelerate at a CAGR of 3.4% |
Market Growth 2023-2027 |
908.49 million US dollars |
Market structure |
Torn apart |
Year-on-year growth 2022-2023 (%) |
3.3 |
Regional analysis |
North America, Europe, Asia and Rest of World (ROW) |
Effective market contribution |
North America with 38% |
Key countries |
USA, Canada, Germany, UK and China |
The competitive environment |
Leading suppliers, market positioning of suppliers, competitive strategies and industry risks |
Key companies profiled |
Bayer AG, Alkem Laboratories Ltd., Apotex Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, iNova Pharmaceuticals, Johnson and Johnson, Lupine Ltd., Perrigo Co. Plc, Pfizer Inc., SRS Life Sciences Pte. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., The Procter and Gamble Co. and Abbott Laboratories |
Market dynamics |
Major market analysis, drivers and barriers to market growth, fast and slow growing segment analysis, analysis of the impact and recovery of COVID-19 and future consumer dynamics, and market status analysis for the forecast period. |
Range of customization |
If our report doesn’t include the data you’re looking for, you can contact our analysts and get custom segments. |
Contents:
1 Summary
2 Market landscape
3 Sizing the market
4 Historical market size
5 Five Forces Analysis
6 Market segmentation by route of administration
7 Market Segmentation by Type
8 Customer landscape
9 Geographical landscape
10 Drivers, challenges and trends
11 Supplier landscape
12 Supplier Analysis
13 Appendix
About us
Technavio is a leading global technology research and consulting company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 dedicated analysts, Technavio’s report library consists of more than 17,000 reports and growing, covering 800 technologies spanning 50 countries. Their client base consists of businesses of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, in-depth research and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media and Marketing Executive
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
View Original Media Download Content: https://www.prnewswire.com/news-releases/gerd-market-size-to-increase-by-usd-908-49-million-north-america-to-account- for -38-on-market-growth—technavio-301728015.html
SOURCE Technavio